# FDA Inspection 1007909 - Vogelzang, Nicholas J., M.D. - March 16, 2017

Source: https://www.keypedia.com/records/fda_inspections/vogelzang-nicholas-j-md/03f64db4-62ef-40f0-9241-d36478a575a2
Source feed: FDA_Inspections

> FDA Inspection 1007909 for Vogelzang, Nicholas J., M.D. on March 16, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007909
- Company Name: Vogelzang, Nicholas J., M.D.
- Inspection Date: 2017-03-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1173738 - 2022-06-21](https://www.keypedia.com/records/fda_inspections/vogelzang-nicholas-j-md/3773986f-3ebb-457f-9284-6ad1ca490614)
- [FDA Inspection 612067 - 2009-08-18](https://www.keypedia.com/records/fda_inspections/vogelzang-nicholas-j-md/89bb3c5d-5c14-47f2-b39e-18e89f8bc698)

Company: https://www.keypedia.com/companies/vogelzang-nicholas-j-md/095182bb-08b5-4357-a536-001ea38f5d54

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c